Identification of the Aedes aegypti nAChR gene family and molecular target of spinosad

Pest Manag Sci. 2021 Apr;77(4):1633-1641. doi: 10.1002/ps.6183. Epub 2020 Dec 10.

Abstract

Background: Spinosad is an insecticide with unique mode of action (MOA) of disrupting nicotinic acetylcholine receptor and is efficacious against many insect species. Mutations in the nicotinic acetylcholine receptor (nAChR) α6 subunit have been identified that are associated with levels of spinosad resistance, but the molecular characterization of the nAChR gene family and a causative association between nAChR α6 and resistance to spinosad in Aedes aegypti, a primary vector of many arboviruses, have not yet been reported.

Results: In this study, we identified 10 candidate nAChR subunits in Ae. Aegypti, nAChRα1-α9 and nAChRβ1, showing similarly orthologous relationships with Anopheles gambiae. With the application of the CRISPR/Cas9 genome editing system, we introduced a 32-bp deletion at the 5' end of the Aaeα6 (Ae. aegypti nAChR α6) gene in a homozygous mutant strain (Aaeα6-KO). The mutation produced two successive pre-mature stop codons, resulting in loss of function in the target receptor. The Aaeα6-KO mutant strain exhibited a 320-fold level of resistance to spinosad compared with wildtype. A recessive mode of inheritance for spinosad resistance was found in the Aaeα6-KO strain.

Conclusion: CRISPR/Cas9 introduced truncated Aaeα6 receptor in Ae. aegypti resulted in an increased level of resistance to spinosad, suggesting that the conserved nAChR α6 subunit is the target for spinosad insecticide. © 2020 Society of Chemical Industry.

Keywords: Aedes aegypti; CRISPR/Cas9; nAChR α6; resistance; spinosad.

MeSH terms

  • Aedes* / genetics
  • Animals
  • Drug Combinations
  • Insecticide Resistance / genetics
  • Insecticides* / pharmacology
  • Macrolides / pharmacology
  • Mosquito Vectors
  • Receptors, Nicotinic* / genetics

Substances

  • Drug Combinations
  • Insecticides
  • Macrolides
  • Receptors, Nicotinic
  • spinosad